Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 2005
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aortaT Schultheiss, K Flau, M Kathmann, et al.
British Journal of Pharmacology|August 1, 1994
Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor modelsE Schlicker, M Kathmann, S Reidemeister, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 17, 2009
Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266J Günther, K Schulte, D Wenzel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 25, 2001
Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptorsB Malinowska, J Piszcz, B Koneczny, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 29, 2000
Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptorsM Nakazi, U Bauer, T Nickel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2001
Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterolW Fischer, H Kittner, R Regenthal, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1992
Mutual interaction of histamine H3-receptors and alpha 2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortexE Schlicker, A Behling, G Lümmen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1991
Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH1-24, angiotensin II, bradykinin and delta-sleep-inducing peptideE Schlicker, G Gross, K Fink, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 5, 2009
Role of endocannabinoids in cardiovascular shockB Malinowska, S Lupinski, G Godlewski, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 1999
The stereoselective kappa-opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptorU Bauer, M Nakazi, M Kathmann, et al.
Pageof 13